Skip to main content

Laryngoscopy

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

KARL STORZ Endoscopy
KARL STORZ EndoscopyCA - El Segundo
1 program
Macintosh laryngoscopeN/A1 trial
Active Trials
NCT00602979Completed240Est. Jul 2011
Medtronic
MedtronicNJ - Phillipsburg
1 program
remifentanil infusionN/A1 trial
Active Trials
NCT00926718Unknown80

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Medtronicremifentanil infusion
KARL STORZ EndoscopyMacintosh laryngoscope

Clinical Trials (2)

Total enrollment: 320 patients across 2 trials

NCT00926718Medtronicremifentanil infusion

The Effect of Rocuronium on the Response of Composite Variability Index (CVI) to Laryngoscopy

Start: Jun 200980 patients
N/AUnknown
NCT00602979KARL STORZ EndoscopyMacintosh laryngoscope

Comparison Study in Adult Surgical Patients of 5 Airway Devices

Start: Apr 2008Est. completion: Jul 2011240 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.